Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
出版年份 2020 全文链接
标题
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-01
DOI
10.1007/s00535-020-01733-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis
- (2020) Yasuhiro Asahina et al. HEPATOLOGY RESEARCH
- Glecaprevir and Pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study
- (2019) Eiichi Ogawa et al. HEPATOLOGY RESEARCH
- Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
- (2019) Toshie Mashiba et al. HEPATOLOGY RESEARCH
- Intention‐to‐treat Assessment of Glecaprevir + Pibrentasvir Combination Therapy for Patients with Chronic Hepatitis C in the Real World
- (2019) Akihiro Tamori et al. HEPATOLOGY RESEARCH
- Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
- (2019) Shohei Tsuji et al. HEPATOLOGY RESEARCH
- Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
- (2018) Hidenori Toyoda et al. JOURNAL OF GASTROENTEROLOGY
- Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
- (2018) Keiji Tsuji et al. JOURNAL OF GASTROENTEROLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
- (2018) Tetsuo Takehara et al. JOURNAL OF GASTROENTEROLOGY
- Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)
- (2018) Ivan Gentile et al. Hepatology International
- The presence of varices in patients after hepatitis C eradication predicts deterioration in the FIB‐4 index
- (2018) Yuya Seko et al. HEPATOLOGY RESEARCH
- Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
- (2017) Carlos Fernández Carrillo et al. HEPATOLOGY
- Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
- (2016) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Michelle C.M. Cheung et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started